Literature DB >> 9848606

The dilemma of MDR-TB in the global era.

P Farmer1, J Bayona, M Becerra, J Furin, C Henry, H Hiatt, J Y Kim, C Mitnick, E Nardell, S Shin.   

Abstract

Mesh：

Year:  1998        PMID： 9848606

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  33 in total

1.  Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis.

Authors:  Elena Bogatcheva; Colleen Hanrahan; Boris Nikonenko; Rowena Samala; Ping Chen; Jacqueline Gearhart; Francis Barbosa; Leo Einck; Carol A Nacy; Marina Protopopova
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

2.  Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries.

Authors:  Cindy Maria Quezada; Eliane Kamanzi; Julienne Mukamutara; Pim De Rijk; Leen Rigouts; Françoise Portaels; Yanis Ben Amor
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

Review 3.  The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.

Authors:  S Basu; A P Galvani
Journal:  Epidemiol Infect       Date:  2008-07-07       Impact factor: 2.451

Review 4.  Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

Authors:  P Farmer; J Y Kim
Journal:  BMJ       Date:  1998-09-05

5.  An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition.

Authors:  Michelle Lay Teng Ang; Siti Zarina Zainul Rahim; Zarina Zainul Rahim Siti; Guanghou Shui; Petronela Dianiškova; Jan Madacki; Wenwei Lin; Vanessa Hui Qi Koh; Julia Maria Martinez Gomez; Sukumar Sudarkodi; Anne Bendt; Markus Wenk; Katarína Mikušová; Jana Korduláková; Kevin Pethe; Sylvie Alonso
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

6.  To Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant Tuberculosis.

Authors:  Jennifer Furin; Helen Cox
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

7.  Multicenter evaluation of genechip for detection of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Yu Pang; Hui Xia; Zhiying Zhang; Junchen Li; Yi Dong; Qiang Li; Xichao Ou; Yuanyuan Song; Yufeng Wang; Richard O'Brien; Kai Man Kam; Junying Chi; Shitong Huan; Daniel P Chin; Yanlin Zhao
Journal:  J Clin Microbiol       Date:  2013-03-20       Impact factor: 5.948

8.  Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.

Authors:  Gabriel M Cohen; Paul K Drain; Farzad Noubary; Christie Cloete; Ingrid V Bassett
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

9.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 10.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.